You have 9 free searches left this month | for more free features.

Vincristine Sulfate Liposome

Showing 1 - 25 of 1,755

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Blasts 5 Percent or More of Bone Marrow Nucleated Cells, Blasts 5

Withdrawn
  • Allogeneic Hematopoietic Stem Cell Transplantation Recipient
  • +7 more
  • Inotuzumab Ozogamicin
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 13, 2022

Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Mantle-Cell Trial in Providence (Rituximab, Bendamustine, Vincristine

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • +5 more
  • Providence, Rhode Island
    Rhode Island Hospital and The Miriam Hospital
Jul 19, 2021

Intraocular Retinoblastoma Trial in United States (drug, procedure, biological)

Completed
  • Intraocular Retinoblastoma
  • liposomal vincristine sulfate
  • +5 more
  • Arcadia, California
  • +10 more
Jul 12, 2021

Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston

Recruiting
  • Recurrent Acute Lymphoblastic Leukemia
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 21, 2022

Hematologic Diseases Trial (Vincristine Sulfate Liposome, CHOP, R-CHOP)

Unknown status
  • Hematologic Diseases
  • Vincristine Sulfate Liposome
  • +2 more
  • (no location specified)
Apr 15, 2020

Recurrent Adult Acute Myeloid Leukemia Trial in Winston-Salem (Vincristine Sulfate Liposome, Laboratory Biomarker Analysis)

Terminated
  • Recurrent Adult Acute Myeloid Leukemia
  • Vincristine Sulfate Liposome
  • Laboratory Biomarker Analysis
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 31, 2019

Diffuse Large B-cell Lymphoma Trial (Rituximab, Mitoxantrone HCl liposome, Cyclophosphamide)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • (no location specified)
Mar 9, 2023

Rhabdomyosarcoma, Child Trial (Doxorubicin Hydrochloride Liposome+Irinotecan, Temozolomide+Irinotecan+Vincristine)

Not yet recruiting
  • Rhabdomyosarcoma, Child
  • (no location specified)
Jul 13, 2022

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Seattle (drug, other, biological)

Completed
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 18, 2022

Malignant Melanoma Trial in Houston (Vincristine Sulfate Liposomes Injection)

Completed
  • Malignant Melanoma
  • Vincristine Sulfate Liposomes Injection
  • Houston, Texas
    University of Texas M.D. Anderson Cancer Center
Dec 10, 2019

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage Trial in Houston (Clofarabine,

Recruiting
  • Acute Bilineal Leukemia
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Intraocular Retinoblastoma Trial in Worldwide (liposomal vincristine sulfate, carboplatin, etoposide)

Completed
  • Intraocular Retinoblastoma
  • liposomal vincristine sulfate
  • +2 more
  • Birmingham, Alabama
  • +55 more
Feb 16, 2021

Non-Hodgkin's Lymphoma, Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma Trial in San Francisco, Leeds (Vincristine Sulfate

Completed
  • Non-Hodgkin's Lymphoma
  • +2 more
  • Vincristine Sulfate Liposome Injection plus rituximab
  • San Francisco, California
  • +1 more
Dec 31, 2019

Stage I Mantle Cell Lymphoma, Stage II Contiguous Mantle Cell Lymphoma, Stage II Non-Contiguous Mantle Cell Lymphoma Trial in

Active, not recruiting
  • Stage I Mantle Cell Lymphoma
  • +4 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +8 more
  • Buffalo, New York
  • +1 more
Mar 9, 2022

Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma Trial in United

Recruiting
  • Acute Adult T-Cell Leukemia/Lymphoma
  • +3 more
  • Atlanta, Georgia
  • +13 more
Jan 26, 2023

B-cell Acute Lymphoblastic Leukemia Trial in Tampa, Durham, Winston-Salem (Blinatumomab)

Withdrawn
  • B-cell Acute Lymphoblastic Leukemia
  • Tampa, Florida
  • +2 more
Feb 14, 2022

AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell

Completed
  • AIDS-related Diffuse Large Cell Lymphoma
  • +8 more
  • Eldoret, Kenya
  • +1 more
Sep 12, 2022

Solid Tumors, Primary Brain Tumors Trial in United States (Vincristine, Irinotecan, Temozolomide)

Completed
  • Solid Tumors
  • Primary Brain Tumors
  • Hartford, Connecticut
  • +13 more
Jan 12, 2023

Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage I Adult

Completed
  • Contiguous Stage II Adult Lymphoblastic Lymphoma
  • +5 more
  • Sacramento, California
    University of California Davis
Mar 8, 2022

Anaplastic Large Cell Lymphoma, ALK-Negative, Anaplastic Large Cell Lymphoma, ALK-Positive, Hepatosplenic T-Cell Lymphoma Trial

Completed
  • Anaplastic Large Cell Lymphoma, ALK-Negative
  • +9 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +8 more
  • Duarte, California
  • +7 more
Nov 4, 2022

MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

Recruiting
  • Myelodysplastic Syndromes, de Novo
  • +10 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 23, 2023

Multiple Myeloma and Plasma Cell Tumor Trial in Buffalo (dexamethasone, doxorubicin HCl, thalidomide)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 30, 2022

Neuroblastoma Trial in Canada, United States (131I-MIBG, Vincristine, Irinotecan)

Completed
  • Neuroblastoma
  • 131I-MIBG
  • +3 more
  • Los Angeles, California
  • +13 more
May 16, 2022

Diffuse Large B-cell Lymphoma Trial in Changchun (Mitoxantrone HCl liposome injection, RiTUXimab Injection, Cyclophosphamid)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • Mitoxantrone hydrochloride liposome injection
  • +4 more
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Aug 15, 2023